Research Article

Distribution of Peripheral Lymphocyte Populations in Primary Sjögren’s Syndrome Patients

Table 3

Distribution of CD4+ lymphocyte subpopulations in peripheral blood of pSS patients and controls.

Patients1I-controls2II-pSS Abs3III-pSS Abs+
I-III-IIIII-III

CD4+ lymphocyte populations
 CD4+CD25+
  %410.00 ± 10.949.72 ± 6.111.64 ± 9.38NSNSNS
  A. count#183.6 ± 222.3132.7 ± 106.0106.1 ± 75.89NS0.036NS
 CD4+CD25high
  %41.97 ± 1.3422.45 ± 1.712.71 ± 1.83NSNSNS
  A. count#32.13 ± 25.8831.81 ± 25.9224.39 ± 13.50NSNSNS
 CD4+FoxP3
  %44.56 ± 4.735.19 ± 6.695.012 ± 4.68NSNSNS
  A. count#75.25 ± 82.6259.45 ± 72.8362.62 ± 105.0NSNSNS
 CD4+CD25+FoxP3
  %41.12 ± 2.091.10 ± 0.900.90 ± 0.63NSNSNS
  A. count#19.12 ± 42.3313.19 ± 10.7910.21 ± 13.65NSNSNS
 CD4+CD25highFoxP3
  %40.27 ± 0.340.36 ± 0.310.35 ± 0.27NSNSNS
  A. count#4.45 ± 6.94.039 ± 2.913.26 ± 2.81NSNSNS
 CD4+CD25lowFoxP3
  %40.84 ± 1.750.78 ± 0.730.57 ± 0.51NSNSNS
  A. count#14.57 ± 35.469.64 ± 9.6126.71 ± 12.78NS0.017NS
 Th17
  %42.08 ± 1.310.85 ± 1.081.51 ± 2.890.00030.004NS
  A. count#34.44 ± 21.029.12 ± 10.8910.89 ± 22.71<0.0001<0.0001NS

I group: healthy controls; 2II group: pSS patients without anti-SSA/SSB; 3III group: pSS patients with anti-SSA and/or anti-SSB; %4: proportion of all CD4+ lymphocytes; A. count#: absolute count of cells in 1 μL of blood. *Mann-Whitney test. NS: not significant.